Evid Invest
Who owns URGNWhat URGN owns — n/a

Who owns UroGen Pharma Ltd.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of URGN from SEC Form 13F filings across 220 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 220 institutions disclosed 40.6M shares of UroGen Pharma Ltd. worth $1.73B — about 80.2% of shares outstanding; the largest disclosed holder is RTW INVESTMENTS, LP. Source: SEC Form 13F filings, parsed by EvidInvest.

220

13F holders

$1.73B

value, 2026 filers

80.2%

of shares outstanding (40.6M sh)

52

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of URGN's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1RTW INVESTMENTS, LP4.5M$184.6M1.9%9%0.0%
2BlackRock, Inc.3.1M$126.3M0.0%6.1%-2.9%
3Kynam Capital Management, LP2.4M$98.9M5.5%4.8%0.0%
4Jefferies Financial Group Inc.2.2M$89.4M0.7%4.4%0.0%
5MORGAN STANLEY2.2M$88.4M0.0%4.3%-15.6%
6ACORN CAPITAL ADVISORS, LLC1.6M$67.0M18.4%3.3%-1.5%
7Opaleye Management Inc.1.4M$58.5M6.6%2.8%0.0%
8AMERICAN CENTURY COMPANIES INC1.4M$55.9M0.0%2.7%-18.4%
9D. E. Shaw & Co., Inc.1.3M$52.2M0.0%2.5%+12.0%
10SILVERARC CAPITAL MANAGEMENT, LLC1.1M$46.7M5.5%2.3%-11.8%
11ORBIMED ADVISORS LLC988,487$40.2M0.7%2%+46.2%
12STATE STREET CORP975,787$39.6M0.0%1.9%-2.7%
13FRONTIER CAPITAL MANAGEMENT CO LLC936,144$38.0M0.4%1.9%-37.9%
14MPM BIOIMPACT LLC909,691$37.0M2.7%1.8%-2.5%
15GOLDMAN SACHS GROUP INC848,342$34.5M0.0%1.7%+3.5%
16Migdal Insurance & Financial Holdings Ltd.770,909$31.3M0.2%1.5%0.0%
17Parkman Healthcare Partners LLC750,202$30.5M2.7%1.5%+331.0%
18GEODE CAPITAL MANAGEMENT, LLC617,513$25.1M0.0%1.2%+1.2%
19Woodline Partners LP500,726$20.3M0.1%1%0.0%
20Boxer Capital Management, LLC500,000$20.3M1.8%1%0.0%
21Elmind Capital, LP491,100$20.0M4.9%1%+309.3%
22VANGUARD PORTFOLIO MANAGEMENT LLC462,075$18.8M0.0%0.9%+1.2%
23TWO SIGMA INVESTMENTS, LP406,299$16.5M0.0%0.8%+172.8%
24ADAR1 Capital Management, LLC369,785$15.0M0.7%0.7%+46.5%
25NOMURA ASSET MANAGEMENT INTERNATIONAL INC.NEW366,973$14.9M0.0%0.7%new

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.